FDA


  • FDA Panel Rejects Lykos Therapeutics’ MDMA for PTSD Application

    FDA Panel Rejects Lykos Therapeutics’ MDMA for PTSD Application

    An FDA advisory panel voted against approving Lykos Therapeutics’ MDMA-assisted therapy…

    Edited by: author David ConnellDavid Connell

  • Cybin’s Psilocybin Program Granted FDA Breakthrough Designation

    Cybin’s Psilocybin Program Granted FDA Breakthrough Designation

    FDA support for psychedelics continues as Cybin’s psilocybin program for depression…

    Written by: Jason NajumJason Najum

  • Psychedelic News Roundup: LSD Receives FDA Breakthrough Status & Canadian Grey-Market Mushroom Store is Back in Business

    Psychedelic News Roundup: LSD Receives FDA Breakthrough Status & Canadian Grey-Market Mushroom Store is Back in Business

    Explore the latest in psychedelic news, including the reinstatement of a…

    Edited by: author David ConnellDavid Connell

  • MindMed Receives FDA Breakthrough Therapy Designation For LSD

    MindMed Receives FDA Breakthrough Therapy Designation For LSD

    Major news in the psychedelic medicine industry as MindMed has received…

    Written by: Jason NajumJason Najum